CAS: 1402345-92-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK-F1 REF: 54-BUP07202CAS: 1402345-92-9 | 95.49% | 804.00 €~1,788.00 € | Mon 21 Apr 25 |
 | GSK-F1 REF: 7W-GW7601CAS: 1402345-92-9 | - - - | 331.00 €~964.00 € | Thu 24 Apr 25 |
 | GSK-F1 REF: TM-T19840CAS: 1402345-92-9 | 95.5% | 110.00 €~1,320.00 € | Thu 03 Jul 25 |
 | rac-GSK-F1 REF: 3D-CGC34592CAS: 1402345-92-9 | Min. 95% | - - - | Discontinued product |
Ref: 54-BUP07202
| 25mg | 804.00 € | ||
| 50mg | 1,071.00 € | ||
| 100mg | 1,270.00 € | ||
| 200mg | 1,788.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Ref: 7W-GW7601
| 1mg | 331.00 € | ||
| 5mg | 656.00 € | ||
| 10mg | 964.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
GSK-F1
CAS:1402345-92-9
GSK-F1 (PI4KA inhibitor-F1) is a novel potent PI4KA inhibitor.
Formula:
C27H18F5N5O4S
Purity:
95.5%
Color and Shape:
Solid
Molecular weight:
603.52
Ref: TM-T19840
| 1mg | 110.00 € | ||
| 5mg | 226.00 € | ||
| 10mg | 335.00 € | ||
| 25mg | 538.00 € | ||
| 50mg | 730.00 € | ||
| 100mg | 938.00 € | ||
| 200mg | 1,320.00 € | ||
| 1mL*10mM (DMSO) | 320.00 € |
Estimated delivery in United States, on Thursday 3 Jul 2025
rac-GSK-F1
CAS:1402345-92-9
GSK-F1 is a peptide that has been shown to activate ion channels and stimulate the …
Formula:
C27H18F5N5O4S
Purity:
Min. 95%
Molecular weight:
603.5 g/mol
Ref: 3D-CGC34592
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
